Fig. 2From: Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver diseaseAdjusted OR from logistic regression analysis evaluating healthy controls versus patients with MASLD (black lines) and patients with MASLD and no/mild fibrosis versus significant fibrosis (red lines). Analyses are adjusted for age and sexBack to article page